Back
Actinium Pharmaceuticals Vs. Cellectar Biosciences Industry Stock Comparison
Sell
24
ATNM
Actinium Pharmaceuticals
Last Price:
6.97
Seasonality Move:
0.26%
Sell
37
CLRB
Cellectar Biosciences
Last Price:
2.39
Seasonality Move:
-11.72%
Sell
24
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $6.97. The Score for ATNM is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- ATNM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy, Sell or Hold?
- The current Cellectar Biosciences [CLRB] share price is $2.39. The Score for CLRB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- CLRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $6.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing slight selling pressure.
CLRB Stock Price Chart
What is Cellectar Biosciences's stock price today?
-
The Cellectar Biosciences share price today is $2.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing slight selling pressure.
ATNM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 36.82 | Sell |
| Chaikin Money Flow: | -26939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.29 - 8.11) | Sell |
| Bollinger Bands (100): | (6.93 - 8.89) | Sell |
CLRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 37.77 | Sell |
| Chaikin Money Flow: | -24074 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 3.21) | Sell |
| Bollinger Bands (100): | (2.91 - 3.77) | Sell |
ATNM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.22 | Sell |
| 20-day SMA: | 7.58 | Sell |
| 50-day SMA: | 8.12 | Sell |
| 200-day SMA: | 6.6 | Buy |
| 8-day EMA: | 7.23 | Sell |
| 20-day EMA: | 7.54 | Sell |
| 50-day EMA: | 7.84 | Sell |
| 200-day EMA: | 7.32 | Sell |
CLRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.53 | Sell |
| 20-day SMA: | 2.86 | Sell |
| 50-day SMA: | 3.03 | Sell |
| 200-day SMA: | 3.05 | Sell |
| 8-day EMA: | 2.54 | Sell |
| 20-day EMA: | 2.75 | Sell |
| 50-day EMA: | 3 | Sell |
| 200-day EMA: | 3.01 | Sell |
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.51 per share, an increase this year of $0.47 per share, and an increase next year of $1.18 per share.
Cellectar Biosciences Earnings Growth & CLRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.05 per share, an increase this year of $1.18 per share, and an increase next year of $1.00 per share.
Actinium Pharmaceuticals Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cellectar Biosciences Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||